Subcutaneous Immunization of Leishmania HSP70-II Null Mutant Line Reduces the Severity of the Experimental Visceral Leishmaniasis in BALB/c Mice

Citation
Solana, J. C., Ramírez, L., Cook, E. C., Hernández-García, E., Sacristán, S., Martín, M. E., Manuel González, V., Reguera, R. M., Balaña-Fouce, R., Fresno, M., Requena, J. M., Iborra, S., & Soto, M. (2020). Subcutaneous Immunization of Leishmania HSP70-II Null Mutant Line Reduces the Severity of the Experimental Visceral Leishmaniasis in BALB/c Mice. Vaccines, 8(1), 141. https://doi.org/10.3390/vaccines8010141
DOI:
DOI: 10.3390/vaccines8010141
Year of publication:
2020
Authors participating in BCBHub:
José Maria Requena Rolanía